Article
Frequent Cross-Resistance to Dapivirine in HIV-1 Subtype C-Infected Individuals after First-Line Antiretroviral Therapy Failure in South Africa.
Antimicrobial agents and chemotherapy - 1 Feb 2017
Penrose Kerri J, Wallis Carole L, Brumme Chanson J, Hamanishi Kristen A, Gordon Kelley C, Viana Raquel V, Harrigan P Richard, Mellors John W, Parikh Urvi M
Abstract excerpt
A vaginal ring containing dapivirine (DPV) has shown moderate protective efficacy against HIV-1 acquisition, but the activity of DPV against efavirenz (EFV)- and nevirapine (NVP)-resistant viruses that could be transmitted is not well defined. We investigated DPV cross-resistance of subtype C HIV-1 from individuals on failing NVP- or EFV-containing antiretroviral therapy (ART) in South Africa. Plasma samples were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
